Signaling Pathways - Type 2 Diabetes - Myeloma
清除全部
- B4763 GKT1378311 CitationTarget: NADPH OxidasesSummary: Nox1/Nox4双重抑制剂
- B6026 VR23Target: ProteasomeSummary: 蛋白酶抑制剂
- B5978 BDA-366Target: Bcl-2Summary: BCL2 BH4 结构域的选择性拮抗剂
- B7794 BMS 3094032 CitationTarget: Fatty-acid-binding proteins (FABPs)Summary: FABP4抑制剂
- B5612 BAY 60-6583Target: Adenosine A2B ReceptorsSummary: A2B受体的强效激动剂
- B6766 CL 316243 disodium saltSummary: 鼠选择性的β3肾上腺素受体激动剂
- B1410 Amlodipine中文名: 氨氯地平Target: Voltage-gated Calcium Channels (CaV)Summary: 钙通道阻滞剂
- B2198 Nateglinide中文名: 那格列奈Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 胰岛素促分泌剂
- B2195 Gliclazide中文名: 格列齐特Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 钾通道抑制剂
- B1564 Ranitidine中文名: 盐酸雷尼替丁Target: Histamine H2 ReceptorsSummary: 组胺H2受体拮抗剂